| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |